🇺🇸 FDA
Patent

US 11730705

Small molecule CMKLR1 antagonists in inflammatory disease

granted A61KA61K31/133A61K31/135

Quick answer

US patent 11730705 (Small molecule CMKLR1 antagonists in inflammatory disease) held by United States Government as represented by the Department of Veterans Affairs expires Mon Aug 17 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United States Government as represented by the Department of Veterans Affairs
Grant date
Tue Aug 22 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 17 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K31/133, A61K31/135, A61K31/14, A61P